Vasoactive Intestinal Peptide (VIP) requires precise reconstitution and handling techniques to maintain secondary structure integrity and bioactivity in laboratory assays. This protocol outlines standard operating procedures for reconstituting, calculating concentrations, and storing research-grade VIP synthesized for in vitro and preclinical research applications.
Vasoactive Intestinal Peptide (VIP) requires precise reconstitution and handling techniques to maintain secondary structure integrity and bioactivity in laboratory assays. This protocol outlines standard operating procedures for reconstituting, calculating concentrations, and storing research-grade VIP synthesized for in vitro and preclinical research applications.
Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuropeptide belonging to the glucagon/secretin superfamily. In preclinical research models, VIP acts as a potent signaling molecule targeting VPAC1 and VPAC2 G-protein coupled receptors. In vitro assays demonstrate its role in modulating adenylate cyclase activity, cellular cAMP accumulation, cytokine release pathways, and vascular smooth muscle tone.
Due to its amphipathic alpha-helical structure and sensitivity to enzymatic cleavage or oxidation, maintaining strict handling protocols during reconstitution is critical. When researchers source vasoactive intestinal peptide for controlled laboratory investigations, understanding the physical chemistry of the lyophilized powder ensures reproducible assay outcomes and prevents premature peptide degradation.
Lyophilized VIP presents as a white, electrostatic crystalline or amorphous cake. In its freeze-dried state, the peptide is stabilized using precise trifluoroacetate (TFA) counter-ion ratios or acetate salt formulations. The primary sequence contains several basic residues (lysine and arginine) alongside methionine and tryptophan, making it hydrophobic yet inherently soluble in aqueous media under neutral to slightly acidic pH conditions.
Preclinical evaluation shows that VIP rapidly dissolves in sterile aqueous diluents such as bacteriostatic water (0.9% benzyl alcohol in sterile water) or phosphate-buffered saline (PBS, pH 7.4). However, agitation must be strictly minimized. Vortexing can introduce shear stress, leading to surface denaturation, aggregation, or precipitation of the peptide chain. For complete guidelines on managing freeze-dried reagents, consult our detailed resource on lyophilized peptide storage guidelines.
To perform a standard VIP reconstitution protocol within a biosafety cabinet or laminar flow hood, laboratory personnel should gather the following sterile equipment and research-grade reagents:
1. High-purity lyophilized VIP peptide vial (e.g., 2 mg or 5 mg mass per vial). 2. Bacteriostatic water (0.9% benzyl alcohol) or Sterile Water for Injection (SWFI) for single-use assays. 3. Sterile 1.5 mL or 2.0 mL polypropylene microcentrifuge tubes (low-binding preferred to prevent peptide adsorption). 4. Calibrated single-channel micropipettes (P20, P200, P1000) with sterile, filter-barrier tips. 5. 70% Isopropyl alcohol wipes for septum decontamination. 6. Polypropylene cryovials for ultra-low temperature storage (-80°C).
Adherence to aseptic technique is paramount when preparing research peptides for cell culture or enzymatic assays. Follow this sequential protocol for safe, accurate reconstitution:
Step 1: Sanitize Workstation and Vial Septum. Clean the laminar flow surface with 70% ethanol. Remove the plastic flip-top seal from the VIP vial and wipe the rubber stopper with an isopropyl alcohol swab. Allow the stopper to air-dry completely for 30 seconds to prevent alcohol contamination of the lyophilizate.
Step 2: Calculate Solvent Volume. Determine the desired working stock concentration. For example, adding 2.0 mL of reconstituting solvent to a 2 mg vial yields a stock solution concentration of 1.0 mg/mL (1000 µg/mL).
Step 3: Solvent Addition. Using a sterile syringe or micropipette, draw up the precise volume of diluent. Insert the needle or tip through the center of the rubber stopper at a 45-degree angle. Direct the stream of liquid slowly down the inner glass wall of the vial. Do not spray the diluent directly onto the freeze-dried peptide mass.
Step 4: Gentle Dissolution. Allow the vial to rest undisturbed at laboratory ambient temperature (20°C–22°C) for 2 to 5 minutes. Gently swirl or roll the vial between your palms until the lyophilizate is completely dissolved into a clear, colorless solution. Do not shake or vortex.
Step 5: Visual Verification. Inspect the solution under bright laboratory light to verify absolute clarity. The solution must be free of particulate matter, turbidity, or undissolved solid flakes. If working with automated liquid handling setups, refer to our peptide reconstitution guide for automated concentration verification algorithms.
Accurate dilution math is required to calculate molarity and mass concentration for in vitro receptor binding assays or microfluidic perfusion studies. The fundamental formula used across laboratory applications is $C_1 V_1 = C_2 V_2$, where $C$ represents concentration and $V$ represents volume.
To calculate the concentration ($C$) of reconstituted VIP: $C = \frac{\text{Mass of Peptide (mg)}}{\text{Volume of Diluent (mL)}}$. For instance, dissolving 5 mg of VIP in 2.5 mL of diluent produces a stock solution of $2.0\text{ mg/mL}$ ($2000\text{ µg/mL}$). If a downstream cell culture assay requires a $10\text{ µM}$ working concentration, use the formula $Molarity = \frac{\text{Mass Concentration (g/L)}}{\text{Molecular Weight (g/mol)}}$. VIP has a molecular mass of approximately $3325.8\text{ g/mol}$. A stock solution of $1\text{ mg/mL}$ ($0.001\text{ g/mL}$) equates to approximately $300.68\text{ µM}$. To prepare $1\text{ mL}$ of a $10\text{ µM}$ assay solution, transfer $33.25\text{ µL}$ of the $1\text{ mg/mL}$ stock solution into $966.75\text{ µL}$ of culture medium.
The choice of reconstitution medium depends on the intended shelf life and downstream experimental applications:
Bacteriostatic Water (0.9% Benzyl Alcohol): Recommended for multi-use research stock solutions held at 2°C–8°C for up to 28 days. Benzyl alcohol acts as a bacteriostatic preservative, inhibiting microbial growth during repeated needle insertions.
Sterile Water for Injection (SWFI) / Deionized Water: Ideal for immediate single-use assays or applications sensitive to benzyl alcohol, such as delicate primary cell cultures or electrophysiological recordings.
Phosphate-Buffered Saline (PBS) / TRIS Buffers: Preferred when working stocks must be maintained at physiological pH (7.4) for immediate downstream binding assays. However, lyophilized VIP should initially be dissolved in a minimal volume of sterile water before adding buffered saline to prevent salt-induced precipitation of the un-hydrated peptide.
For specialized cell-based workflows requiring precise endotoxin limits, ensure your diluents align with our endotoxin testing procedures standards.
Un-reconstituted, lyophilized VIP remains stable at -20°C for up to 24 months, or at -80°C for extended archival storage. Once reconstituted in aqueous solution, peptide stability rapidly declines if subjected to repeated thermal cycling.
To prevent degradation caused by freeze-thaw cycles, reconstitute the full vial mass, then immediately partition the stock solution into single-use micro-aliquots (e.g., 20 µL to 100 µL) inside low-binding polypropylene tubes. Freeze the working aliquots immediately at -80°C. Frozen liquid aliquots typically remain stable for 3 to 6 months. Thaw individual aliquots on ice prior to execution of assays, and discard any unused portion after 24 hours at 4°C.
VIP belongs to the glucagon/secretin superfamily of peptide hormones. When compared to structurally or functionally related research peptides such as PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide) and secretin, as well as unrelated amphipathic research peptides like LL-37, VIP exhibits distinct dissolution kinetics and stability profiles in solution.
While PACAP shares substantial sequence homology and binds the VPAC1 and VPAC2 receptors alongside its selective PAC1 receptor, PACAP-38 possesses a higher basic charge profile, making it slightly more soluble in pure water but more prone to glass surface adsorption. Secretin, sharing a similar 27-amino acid backbone, displays higher sensitivity to deamidation at neutral pH compared to VIP. Antimicrobial peptides like LL-37 readily form higher-order oligomers in ionic buffers, whereas VIP remains predominantly monomeric in dilute aqueous solutions below $1\text{ mM}$. Understanding these distinct thermodynamic behaviors allows investigators to optimize reconstitution protocols across different peptide classes within the PX1 research library.
Consistent experimental results demand ultra-pure research reagents. PX1 Research synthesizes all peptides in state-of-the-art USA-based, ISO 17025 accredited and GMP-compliant facilities. Every production batch undergoes rigorous high-performance liquid chromatography (HPLC) and mass spectrometry (MS) verification to guarantee batch purity exceeding 98%.
Furthermore, every lot of VIP is independently tested for bacterial endotoxin contamination (LAL assay) to ensure compatibility with sensitive cell lines and animal models. Detailed lot-specific Certificates of Analysis (COA) are available for all compounds. Principal investigators and procurement officers seeking larger volume orders for multi-center studies can establish a dedicated wholesale laboratory account to access customized batch sizes, automated lot retention, and expedited fulfillment.
What is the primary keyword and purpose of this VIP reconstitution protocol?
The primary keyword is 'vip reconstitution'. This protocol provides standardized laboratory instructions for dissolving, calculating concentrations of, and storing research-grade VIP for in vitro and preclinical research applications.
Can reconstituted VIP stock solutions be vortexed?
No. Shaking or vortexing reconstituted VIP can cause physical denaturation, foaming, and peptide aggregation due to surface tension stress. Dissolve the peptide by gentle inversion or rolling of the vial.
How long does reconstituted VIP remain stable in bacteriostatic water?
When reconstituted in bacteriostatic water (0.9% benzyl alcohol) and held at 2°C–8°C, VIP solutions remain stable for up to 28 days. For multi-month storage, stock solutions should be aliquoted and stored at -80°C.
What volume of bacteriostatic water should be added to a 2 mg VIP vial?
Adding 2.0 mL of reconstituting diluent to a 2 mg vial yields a convenient working stock concentration of 1.0 mg/mL (1000 µg/mL), simplifying subsequent volumetric dilutions.
Why is low-binding plastic recommended for VIP aliquots?
Like many hydrophobic neuropeptides, VIP can adsorb to non-treated glass or standard polypropylene tube surfaces, reducing the effective concentration of the solution. Low-binding microcentrifuge tubes minimize non-specific binding loss.
Is VIP suitable for human administration or clinical use?
No. All products provided by PX1 Research, including VIP, are sold strictly as research compounds for in vitro laboratory research and preclinical testing only. They are not for human or animal medical, therapeutic, or clinical use.
What analytical methods verify the purity of PX1 Research VIP?
Every lot of VIP from PX1 Research is verified via High-Performance Liquid Chromatography (HPLC) for chemical purity and Mass Spectrometry (MS) for molecular weight confirmation, accompanied by lot-specific COAs.
How does PX1 ship VIP to prevent thermal degradation during transport?
PX1 ships lyophilized peptides from facilities in California and Arizona via climate-controlled packaging with same-day shipping on orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.